Ronan O'Brien is CCO, GC, & Secretary of Pear Therapeutics, Inc.. Currently has a direct ownership of 18,638 shares of PEAR, which is worth approximately $186. The most recent transaction as insider was on Jan 20, 2023, when has been sold 12,162 shares (Class A Common Stock) at a price of $1.13 per share, resulting in proceeds of $13,743. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.6K
0% 3M change
0% 12M change
Total Value Held $186

Ronan O'Brien Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2023
SELL
Open market or private sale
$13,743 $1.13 p/Share
12,162 Reduced 39.49%
18,638 Class A Common Stock
Jan 14 2023
BUY
Exercise of conversion of derivative security
-
30,800 Added 50.0%
30,800 Common Stock
RO

Ronan O'Brien

CCO, GC, & Secretary
Boston, MA

Track Institutional and Insider Activities on PEAR

Follow Pear Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEAR shares.

Notify only if

Insider Trading

Get notified when an Pear Therapeutics, Inc. insider buys or sells PEAR shares.

Notify only if

News

Receive news related to Pear Therapeutics, Inc.

Track Activities on PEAR